Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Return
35.69%
This Quarter Return
-16.46%
1 Year Return
+35.69%
3 Year Return
+149.71%
5 Year Return
+223.91%
10 Year Return
+784.38%
AUM
$11.7B
AUM Growth
-$2.52B
(-18%)
Cap. Flow
-$281M
Cap. Flow
% of AUM
-2.39%
Top 10 Holdings %
Top 10 Hldgs %
19.08%
Holding
289
New
40
Increased
99
Reduced
91
Closed
49
Top Buys
| 1 |
Marathon Petroleum
MPC
|
$176M |
| 2 |
McDonald's
MCD
|
$105M |
| 3 |
IBM
IBM
|
$88.7M |
| 4 |
Bank of America
BAC
|
$87.7M |
| 5 |
Broadcom
AVGO
|
$79.7M |
Top Sells
| 1 |
ANDV
Andeavor
ANDV
|
$232M |
| 2 |
Wells Fargo
WFC
|
$98.7M |
| 3 |
CME Group
CME
|
$95.7M |
| 4 |
Bristol-Myers Squibb
BMY
|
$90.9M |
| 5 |
Alibaba
BABA
|
$88.7M |
Sector Composition
| 1 | Technology | 25.14% |
| 2 | Healthcare | 17.2% |
| 3 | Industrials | 12.75% |
| 4 | Consumer Discretionary | 11.91% |
| 5 | Financials | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
176
CME Group
CME
$93.8B
| $14.2M | 0.12% |
75,737
-508,744
| -87% | -$95.7M |
|
177
Fate Therapeutics
FATE
$115M
| $14.2M | 0.12% |
1,104,305
+272,235
| +33% | +$3.49M |
|
|
IPHI
178
DELISTED
INPHI CORPORATION
IPHI
| $13.3M | 0.11% |
414,870
+240,880
| +138% | +$7.74M |
|
179
Permian Resources
PR
$9.62B
| $13.3M | 0.11% |
1,209,310
-283,160
| -19% | -$3.12M |
|
180
Hamilton Lane
HLNE
$6.45B
| $13.2M | 0.11% |
357,732
-185,513
| -34% | -$6.86M |
|
181
MKS Inc. Common Stock
MKSI
$7.21B
| $12.3M | 0.11% |
190,652
-112,199
| -37% | -$7.25M |
|
182
Evolent Health
EVH
$1.14B
| $12.2M | 0.1% |
610,450
+193,470
| +46% | +$3.86M |
|
|
SMAR
183
DELISTED
Smartsheet Inc.
SMAR
| $12.1M | 0.1% |
+486,968
| New | +$12.1M |
|
|
CORV
184
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $11.8M | 0.1% |
4,737,804
-36,345
| -0.8% | -$90.5K |
|
185
Alarm.com
ALRM
$2.84B
| $11.5M | 0.1% |
221,813
-151,947
| -41% | -$7.88M |
|
|
CTLT
186
DELISTED
CATALENT, INC.
CTLT
| $10.8M | 0.09% |
347,301
-570,715
| -62% | -$17.8M |
|
187
Neurocrine Biosciences
NBIX
$14.3B
| $10.3M | 0.09% |
+143,740
| New | +$10.3M |
|
188
Apellis Pharmaceuticals
APLS
$3.49B
| $10.1M | 0.09% |
767,876
+155,580
| +25% | +$2.05M |
|
189
Abbott
ABT
$231B
| $10.1M | 0.09% |
139,150
-1,070
| -0.8% | -$77.4K |
|
190
National Vision
EYE
$1.82B
| $9.83M | 0.08% |
349,040
-125,585
| -26% | -$3.54M |
|
191
Ultra Clean Holdings
UCTT
$1.12B
| $9.81M | 0.08% |
1,157,993
+146,295
| +14% | +$1.24M |
|
192
Walmart
WMT
$807B
| $9.17M | 0.08% |
295,305
-2,340
| -0.8% | -$72.7K |
|
193
Commault Systems
CVLT
$8.01B
| $8.87M | 0.08% |
150,071
-454,146
| -75% | -$26.8M |
|
|
CBAY
194
DELISTED
Cymabay Therapeutics
CBAY
| $8.47M | 0.07% |
1,076,215
+166,835
| +18% | +$1.31M |
|
195
Matsons
MATX
$3.35B
| $8.45M | 0.07% |
+264,020
| New | +$8.45M |
|
196
Merck
MRK
$210B
| $7.89M | 0.07% |
108,142
-765
| -0.7% | -$55.8K |
|
197
Verizon
VZ
$183B
| $7.84M | 0.07% |
139,525
-1,110
| -0.8% | -$62.4K |
|
198
Advanced Energy
AEIS
$5.87B
| $7.43M | 0.06% |
173,030
-212,973
| -55% | -$9.14M |
|
199
Medtronic
MDT
$119B
| $7.2M | 0.06% |
79,205
+11,945
| +18% | +$1.09M |
|
200
Texas Instruments
TXN
$168B
| $7.17M | 0.06% |
75,835
-600
| -0.8% | -$56.7K |
|